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Background: Assessment of disability is part of the psychiatric diagnostic process, and validated scales are needed for the 
assessment of functioning. The Swedish translations of the Child Sheehan Disability Scale (CSDS) for adolescents and parents 
(CSDS-P) have been adapted for use in psychiatric settings. 
Objective: The purpose of the study was to explore the psychometric properties of the Swedish CSDS and the CSDS-P 
among adolescent psychiatric patients. 
Method: Patients (n = 107) were assessed with the CSDS, the Strengths and Difficulties Questionnaire (SDQ adolescent), 
and the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-
PL) diagnostic interview. Their parents participated in the interview and completed the CSDS-P and SDQ parent. 
Results: Internal consistency was  =.813 for the CSDS (three items) and  =.842 for the CSDS-P (five items). For both 
scales, principal component analyses showed one component. The correlations between the total scores of the CSDS and 
CSDS-P in relation to a general K-SADS-PL symptom summation index were rs = .332, p < .001 and rs = .237, p = .014, 
respectively. Correlations with the total K-SADS function summation index were rs < .300 for both. The correlation between 
the CSDS and the total difficulties score on the SDQ was rs = .433, p < .001.  
Conclusions: The Swedish translations of the CSDS and CSDS-P had similar psychometric properties to Whiteside’s CSDS 
and the Adult Sheehan Disability Scale. Concurrent validity and correlation between the CSDS and CSDS-P were weak. 
 




Within the field of psychiatry, the definition of a 
mental disorder implies significant distress or 
disability in social, occupational and/or other 
activities (1). However, many adolescents have 
multiple mild symptoms, or fewer severe symptoms, 
and do not meet the criteria for a mental disorder. 
Therefore, it is crucial to also consider the level of 
distress and disability in adolescents with psychiatric 
symptoms. Impairment can be measured in terms of 
the level of function (2-5). To assess this level, it is 
important to determine the capacity to perform a task 
in different settings (2-4).  
The International Classification of Impairments, 
Disabilities, and Handicaps was developed in the 
1970s. Using such a classification, the consequence 
of disabilities may be better assessed within a given 
physical and social environment. Some diagnostic 
instruments lack clarity in how to assess domains of 
functioning. For example, Angold et al. (6) indicated 
that a condition may be considered to be 
subthreshold according to the intensity of symptoms 
but can still cause low functioning (6-9). There is also 
a need to improve the measures of adolescent 
functioning and to develop psychometrically sound 
instruments. In psychiatric patients, disability is 
associated with the severity of specific symptoms, the 
number of different symptoms and the number of 
comorbid diagnoses (10, 11). The reduction of 
symptoms corresponds to an improvement in 
occupational and social functioning (12). It has been 
suggested that each diagnosis has its own pattern of 
disability (13, 14). For instance, major depressive 
disorder (MDD) is associated with low physical, 





cognitive and social functioning (15-17), social 
anxiety disorder (SAD) is associated with absence 
from school, isolation and social impairment (7), and 
attention-deficit/hyperactivity disorder (ADHD) 
decreases the ability to sustain attention and 
negatively influences school achievement, peer 
relationships and adjustment in the family (7, 18, 19). 
However, multiple factors beyond a diagnosis are 
related to the level of disability. These include the 
child’s intellectual development, the characteristics 
of the school and peers, and several lifestyle factors 
(20-22). 
Previous research on functioning in adolescents 
has considered it in different settings: at school, with 
peers and at home in the family (20). One instrument 
used to assess functioning in adults is the Sheehan 
Disability Scale (SDS) (8). Moreover, Hörberg et al. 
have indicated that the correlation between the self-
reported SDS score and the expert-rated Global 
Assessment of Functioning (GAF) score in a sample 
of adult patients was (r = - .606) (23).The SDS 
measures function in terms of impairment at 
work/school and in social and family life in adults 
with mental illness, and it is sensitive to change 
during treatment (14, 23-25). Whiteside (9) 
developed the Child Sheehan Disability Scale for self-
report (CSDS) and parent report (CSDS-P) for use 
among children and adolescents (5–19 years) with 
anxiety. The CSDS estimates impairment in 
educational, social and family domains and has 
similar psychometric properties to those of the adult 
SDS. 
To our knowledge, Whiteside (9) has published the 
only study to have applied the CSDS in child 
populations (one clinical and one community 
sample). Whiteside examined the inter-item 
correlation separately for the child and parent scales, 
and, because of the redundancy, the child’s ability to 
function in the family item was replaced by the parent’s 
ability to function in the family item in the parent scale. 
Thereafter, the principal component analysis of the 
CSDS-P found that a one-factor solution explained 
the variance in the parent scale. 
 
Objective 
The objective of this study was to evaluate the 
psychometric properties of the Swedish CSDS and 
CSDS-P in a sample of adolescent psychiatric 




This psychometric study explored the reliability and 
validity of the Swedish versions of the CSDS and 
CSDS-P in an adolescent psychiatric sample. 
Reliability was assessed by exploring internal 
consistency and factor structure. The sensitivity and 
specificity, and appropriate cut-offs of CSDS and 
CSDS-P to identify patients with at least one 
diagnosis versus those without a diagnosis, were 
tested. A functional impairment is a prerequisite for 
just about every diagnosis in psychiatry. Therefore, 
any diagnosis versus no diagnosis was chosen as the 
outcome. Sensitivity (to detect a diagnosis) was set to 
at least 80%, while specificity (to detect those without 
a diagnosis) was set to at least 50%.  
To investigate concurrent validity, the Schedule for 
Affective Disorders and Schizophrenia for School-
Age Children-Present and Lifetime version (K-
SADS-PL) and the Strengths and Difficulties 
Questionnaire (SDQ) were used for comparisons (8, 
9, 26-29). Spearman’s rho correlations were used to 
calculate the concurrent validity of the total score of 
CSDS/CSDS-P and K-SADS. Moreover, the 
correlations between the total scores for CSDS and 
CSDS-P were analyzed, as well as the correlations 
between the items for “school” and “friends” from 
the two scales. 
 
Participants 
The participants were recruited from an ongoing 
cohort study of adolescents seeking help for 
psychiatric problems. Recruitment was performed 
between September 2011 and June 2013. All new 
psychiatric outpatients aged 12–17 years (N = 202) 
and their parents from two clinics in the County of 
Västmanland, Sweden, were invited to participate. 
Exclusion criteria were non-Swedish-speaking 
adolescent/parents or need of in-patient care at the 
time of the K-SADS-PL interview. A total of 125 
(61.9%) patients participated, n = 53 (42.4%) male. 
Of these, 107 adolescents provided full 
information on the K-SADS and CSDS, and 104 
provided full information on the SDQ, while their 
parents completed the CSDS-P (n = 107) and SDQ 
(n = 104) using the Electronic Psychiatric Intake 
Questionnaire (EPIQ) (30) (Figure 1). 
The remaining 18 patients were excluded from the 
study because of a lack of information. Internal drop-
out analysis showed no significant difference in age 
or sex between those who completed the study (n = 
107, 42% male, mean age 15.7 [SD 1.5] years) and 
those who did not (n = 18, 44.4% male, mean age 
15.7 [SD 1.5] years).  
 
Ethical aspects 
The study was conducted in accordance with the 
Declaration of Helsinki (31) and approved by the 
Regional Ethics Committee of Uppsala (Dnr 
2008/214).  
 













At the first visit to the clinic, verbal information 
about the study was given, and informed consent was 
collected from participants. The adolescents 
answered the electronic psychiatric intake 
questionnaire (EPIQ), and parents answered the 
EPIQ-Parent version. Both versions include the 
SDQ. At the second visit, within one week, the 
adolescents and parents were interviewed with the K-
SADS-PL. Thereafter, the adolescents and parents 
reported on the CSDS and the CSDS-P, respectively.  
 
Interviewer training  
The interviewers were trained to perform the K-
SADS interviews. The inter-rater reliability (IRR) was 
good to excellent, both before and during the period 
of data collection. The IRR rate was calculated for 
each diagnosis and each interviewer, and mean IRRs 
were calculated for the group and all diagnoses. 
Overall kappa for the group was .84 (range .54–1.00). 
Mean kappa was .89 for depression disorders, .79 for 
ADHD, and varied from .64 to 1.00 for anxiety 
disorders, as reported previously (32). 
 
Measures 
The CSDS and CSDS-P have been translated into 
Swedish. The original CSDS by Whiteside assesses 
general functioning in relation to “fears and worries” 
(9). In the Swedish version, this was changed to 
general functioning in relation to “troubles and 
feelings”. Three independent experts did the 
translation and back-translation for proper language 
adaptation and finally, the authors of this study 
approved the final translation.  





For layout, see the Swedish CSDS and Swedish 
CSDS-P in Swedish and English in the Appendix. 
 
The Swedish Child Sheehan Disability Scale (Swedish 
CSDS). The Swedish CSDS measures general 
functioning, in relation to “troubles and feelings”. It 
includes three items about functioning at school, 
with friends and at home. The questions are “How 
much do troubles and feelings cause problems for 
you when you are in school and when you do 
homework?”, “How much do troubles and feelings 
cause problems for you when you are with your 
friends?” and “How much do troubles and feelings 
cause problems for you when you are at home?”. The 
score of each item ranges from 0 (“not at all”) to 10 
(“very, very much”), resulting in a total scale range of 
0–30.  
To define patients with low functioning, Leon et al. 
suggested a cut-off score of 5 for the SDS in adult 
primary care populations (25). In addition, Sheehan 
et al. proposed cut-off scores of 1 on each item of 
the SDS and <5 on the total score as remission 
criteria (14). By contrast, Whiteside studied the 
CSDS and the CSDS-P in two samples with a 
primary anxiety disorder and analysed the mean 
values of the most common anxiety diagnoses and 
the effect of the treatment without reference to a 
remission cut-off (9). Based on the SDS studies, a 
cut-off of 5 was chosen to define functional 
impairment on the CSDS (14, 25)  
 
The Swedish Child Sheehan Disability Scale-Parent Report 
(Swedish CSDS-P). The Swedish CSDS-P (parent 
version) is analogous to the Swedish CSDS (child 
version) and has three items that assess the level of 
interference with the parent’s functioning at work 
and in social and family life: “The symptoms have 
disrupted your work”, “The symptoms have 
disrupted your social life” and “The symptoms have 
disrupted your family life/home responsibilities”. 
The CSDS-P also contains an additional two items 
concerning the impact on the child: “The symptoms 
have disrupted your child’s schooling” and “The 
symptoms have disrupted your child’s social life”. 
The score of each item ranges from 0 (“not at all”) to 
10 (“very, very much”), resulting in a total scale range 
of 0–50. In Whiteside’s study (9), the CSDS-P total 
mean (M) and standard deviation (SD) were M = 22.7 
(SD = 11.9) for children with anxiety diagnoses and 
M = 2.89 (SD = 5.5) for the community controls. 
 
Schedule for Affective Disorders and Schizophrenia for School-
Age Children-Present and Lifetime version (K-SADS-PL). 
The K-SADS-PL is a semi-structured diagnostic 
interview that integrates information from children, 
parents and the clinical judgement of the interviewer 
(26, 27). The K-SADS-PL consists of a screening 
interview and eight supplements for 23 diagnostic 
domains (26). It has excellent IRR and test–retest 
reliability supporting its ability to generate valid child 
psychiatric diagnoses (26, 27, 33, 34). In the K-
SADS-PL, comorbidity is presented as the number 
of specific diagnoses. The K-SADS diagnoses are 
grouped as follows: any depression (Major 
Depression, Major Depression with Psychotic 
Features*), any anxiety (Separation Anxiety, Specific 
Phobia, Social Anxiety Disorder, Panic Disorder, 
Agoraphobia, Generalized Anxiety, Obsessive-
Compulsive Disorder, Post-traumatic Stress 
Disorder and Acute Stress Disorder) and any ADHD 
(ADHD combined, predominantly inattentive, 
predominantly hyperactive/impulsive and 
unspecified). At the time of the assessment, the only 
patient with bipolar diagnosis presented a manic 
episode. Moreover, a general K-SADS-PL symptom 
summation index was calculated by adding up the 
obtained scores during the screening interview and 
supplements, in a way analogous to that used by 
Sonnby et al. and Olofsdotter et al. in their previous 
studies (32, 35). The different ranges for symptom 
summation indexes were as follows: depression (0–
114), manic episode (0–52), psychotic disorder (0–
103), panic disorder (0–56), agoraphobia (0–6), 
separation anxiety disorder (0–27), social anxiety 
disorder (0–9), specific phobia (0–56), generalized 
anxiety disorder (0–35), obsessive-compulsive 
disorder (OCD; 0–98), enuresis (0–9), encopresis (0–
9), anorexia nervosa (0–12), bulimia nervosa (0–30), 
ADHD (0–57), oppositional defiant disorder (0–24), 
conduct disorder (0–45), tic disorders (0–56), autism 
(0–43), tobacco use disorder (0–14), alcohol use 
disorders (0–514), drug use disorder (0–53) and post-
traumatic stress disorder (0–66). Scores range from 0 
to 2 or 0 to 3 for each symptom depending on the 
item, and the total range is 0–1488.  
Furthermore, the total K-SADS function summation 
index was calculated by adding the obtained scores of 
summations of function questions of each specific 
diagnosis. Ranges were as follows: depression (0–6), 
manic episode (0–10), psychotic disorder (0–8), panic 
disorder (0–6), separation anxiety disorder (0–6), 
social anxiety disorder (0–6), specific phobia (0–6), 
generalized anxiety disorder (0–6), OCD (0–16), 
ADHD (0–6), oppositional defiant disorder (0–6), 
conduct disorder (0–6), tic disorders (0–6), autism 
(0–6) and post-traumatic stress disorder (0–8). Each 
function question has a score range from 0 to 2, and 
the total K-SADS function summation index is 0–
108. 
 
Strengths and Difficulties Questionnaire (SDQ)–self-report 
and parent versions. The SDQ is a brief behavioural 
screening questionnaire (29). There are equivalent 





versions for adolescents and parents/teachers (28, 
29). Goodman developed the SDQ based on the 
brief Rutter questionnaires and the Child Behaviour 
Checklist (28, 29, 36, 37). The Swedish translation of 
the SDQ parent version has been evaluated with the 
parents of children aged 6–10 years and deemed to 
be a reliable and valid measure (29, 38). Adolescent 
self-reports in Nordic populations show similar 
distributions of SDQ scores, and in a study of 
adolescent self-reports, the emotional subscale of the 
SDQ showed usefulness in differentiating depressed 
from non-depressed cases (39, 40). 
The SDQ consists of 25 items grouped on five 
subscales, each with five items, with each item using 
a three-point Likert scale (0 = not true, 1 = 
somewhat true and 2 = certainly true) (28). The 
subscales produce scores for emotional symptoms, 
conduct problems, hyperactivity-inattention, peer 
problems and prosocial behavior. Some items are 




The chi-square test was used to compare sex and the 
Mann–Whitney U test was used to compare age 
between internal drop-outs and participants with 
complete interviews and forms. 
A principal component analysis with varimax 
rotation was used to evaluate the psychometric 
properties. Internal consistency was assessed with 
Cronbach’s alpha (expected > .7) (41, 42).  
Following Leon et al. (25), the SDS cut-off of 5 was 
used to define patients with low functioning. Because 
of the inherent definition of functional impairment 
related to the determination of any diagnosis, the 
sensitivity and specificity of the CSDS/CSDS-P for 
at least one diagnosis were taken into account (42). 
When at least one diagnosis was confirmed indicating 
low functioning, the optimal cut-offs for CSDS or 
CSDS-P were considered if the sensitivities were 
above 80% and the specificities were not below 50% 
(43) 
Spearman’s rho was used to calculate all 
correlations, including those between a) the 
CSDS/CSDS-P and K-SADS-PL symptom 
summation index, b) the CSDS/CSDS-P and the 
total K-SADS function summation index, c) the 
CSDS/CSDS-P and the K-SADS function 
summation index of each diagnosis, d) the 
CSDS/CSDS-P and SDQ adolescents/SDQ parents, 
respectively, and between the CSDS/CSDS-P and 
the number of diagnoses.  
In addition, this was used to calculate the 
correlations between the total scores of the CSDS 
and the CSDS-P, between the first items of both 
scales (“school” and “child’s school”) and between 
the second items of both scales (“friends” and 
“child’s friends”).   
Spearman’s rho correlations were classified as very 
high (.90–1), high (.70–.90), moderate (.50–.70), low 
(.30–.50) and negligible (0–.30) (44). IBM SPSS 
Statistics for Windows (Armonk, NY, USA), version 
24.0, was used for the statistical analyses. 
 
 
TABLE 1. Descriptive data of the participants 
Participants Total n = 107 Male n = 45 Female n = 62 
Mean age (SD) 15.7 (1.5) 15.5 (1.5) 15.9 (1.4) 
Mean number of disorders (SD) 2.6 (2.1 1.8 (1.2) 3.1 (2.1) 
Groups of K-SADS diagnoses Number (%) Number (%) Number (%) 
ADHD 59 (55.1) 31 (68.9) 28 (45.2) 
Anxiety 58 (54.2) 12 (11.2) 46 (74.2) 
Depression 45 (42.0) 14 (31.1) 31 (50) 
Any other diagnosis 5 (4.6) 2 (4.4) 3 (4.8) 
Without any diagnosis 7 (6.5) 5 (11.1) 2 (3.2) 
SDQ Adolescent Parent  
 Mean score (SD) Mean score (SD)  
Total difficulties score (range 0-40) 16.9 (5.6) 16.6 (5.4)  
Subscale scores (range 0-10)    
 Emotional problems  5.1 (2.8) 5 (2.4)  
 Conduct problems  2.8 (1.6) 2.8 (1.0)  
 Hyperactivity  6.2 (2.3) 5.8 (2.8)  
 Peer problems  2.9 (1.0) 3.1 (2.0)  
 Prosocial*  7.5 (2.1) 7.1 (2.1)  
CSDS (range 0-30) Mean score (SD) CSDS-P (range 0-50) Mean score (SD) 
School 5.2 (3.0) Child’s school 7.2 (2.7) 
Friends 3.5 (2.1) Child’s friends 5.5 (2.7) 
Home 4.2 (3.0)   
  Parent’s work 4.5 (2.9) 
  Parent’s social life 2.7 (2.5) 
  Parent’s life at home 4.6 (2.8) 
Overall mean (all items 4.3 (.9)  4.9 (1.6) 
Total score 12.9 (7.6)  24.5 (10.6) 
Note. *Protective 







Descriptive data of the study group  
There was no significant age difference between the 
internal drop-out group and the study group (U = 
947, p = .910), and no significant sex difference (2 
= .036, p = .850). There was no significant age 
difference between males and females (U = 1202, p 
= .223). The most frequent diagnoses in the study 
sample were ADHD (55.1%), MDD (42.1%) and 
SAD (31%) (Table 1). Diagnoses were grouped into 
any depression (one patient with bipolar diagnosis, 
who presented a manic episode at the time of the 
interview, was not included in depression group), any 
anxiety, any ADHD or any other diagnoses (Table 1). 
Seven patients (6.5%) did not fulfil criteria for any 
diagnosis. 
Five (4.6%) of patients were diagnosed with 
bipolar or psychotic disorders; bipolar depressive 
episode n=1, schizoaffective disorder manic episode 
n=1, and unspecified psychotic disorder n=3. 
 
Psychometric properties of the CSDS and  
CSDS-P 
Factor structure and internal consistency.  
The CSDS showed one component with an 
eigenvalue of 2.19, explaining 72.9% of the variance. 
Items loaded on one component, with a maximum 
for “school” of .868, for “friends”.855 and a 
minimum for “home” of .837. For the CSDS-P, the 
corresponding eigenvalue was 3.09, explaining 61.8% 
of the variance. Items loaded on one component 
with a maximum “for parent’s life at home” of .874, 
for “parent’s work” .861, for “parent’s social 
life”.784, for “child’s friends”.767 and a minimum 
for “child’s school” of .619. Internal consistency was 
Cronbach’s  of .81 for the adolescent scale and .84 
for the parent scale.  
The CSDS at cut-off 5 and the CSDS-P at cut-off 
17 are suggested for the purpose of screening, 
considering a sensitivity above 80% and a specificity 
with a minimum of 50%. The CSDS at cut-off 5 
showed a sensitivity of 85% (85 patients with low 
function out of 100 patients with diagnosis) and 
specificity of 71% (five patients without low function 
out of seven patients without diagnosis) and the 
CSDS-P at cut-off 17 showed a sensitivity of 81% (81 
patients with low function out of 100 patients with 
diagnosis) and specificity of 57% (four patients 
without low function out of seven patients without 




CSDS/CSDS-P in relation to the K-SADS symptom 
summation index. (Not shown in tables). The 
correlation of the CSDS with the K-SADS symptom 
summation index was low (rs = .332, p < .001). 
Furthermore, among the correlations between the 
CSDS and the symptom summation index for each 
diagnosis, only the correlation between the 
adolescent self-report of the CSDS and the 
summation index for MDD was moderate (rs = .500, 
p < .001). Other correlations of the CSDS in relation 
to the summation index for panic disorder (rs = .322, 
p < .001), the summation index for separation anxiety 
(rs = .317, p < .317) and the summation index for 
anorexia (rs = .311, p = .001) were low, and the rest 
were negligible. 
The correlation between the CSDS-P and the K-
SADS symptom summation index and the 
correlations of the CSDS-P with most diagnoses 
were negligible (rs ≤ .300). 
 
Correlations of the CSDS/CSDS-P and the total score K-
SADS function summation index. There were negligible 
correlations for both scales in relation to the total K-
SADS function summation index (rs = .268, p = .006 
and rs = .275, p =.005). With respect to correlations 
between CSDS and the K-SADS function 
summation index of each diagnosis, the correlations 
that stood out were manic episode (rs = .752, p 
= .031), psychotic episode (rs = .741, p = .035), panic 
disorder (rs = .495 p = .043) and social anxiety (rs 
= .327, p = .028). Others were negligible or 
insignificant.  
 
CSDS/CSDS-P in relation to the SDQ adolescent or parent 
version. Table 2 shows that the correlation between 
the CSDS total score and the SDQ adolescent 
subscale score for emotional problems and the 
correlation of the CSDS-P and the total difficulties 
score of the SDQ among parents were low. Prosocial 
sub-scale scores were not included in the correlation 
because these were not considered a direct measure 
of the level of difficulties. 
Relationship between the total score on CSDS/CSDS-P and 
the number of diagnoses. The correlations between the 
CSDS total score and the number of diagnoses were 
low (r = .338, p < .0001); for parents, the correlations 
between the CSDS-P total score and the number of 
diagnoses were negligible (r = .256, p < .008). 
 
Correlations of the CSDS and CSDS-P.  
The correlation for the CSDS total score and CSDS-
P total score was rs = .375, p <.001.  Additionally, the 
correlations between the CSDS “school” item and 
the CSDS-P “Child’s school” item and between the 
CSDS “friends” item, and CSDS-P “Child’s friends” 
were rs = .354, p <.01 and rs = .375, p < .01 
respectively. 
 






TABLE 2. Correlations between the CSDS/CSDS-P and the SDQ adolescent and parent versions measured by 
Spearman’s rho in adolescent psychiatric patients (n =  104) 
SDQ adolescent CSDS total score  SDQ parent CSDS-P total score 
 Spearman’s rho (p)   Spearman’s rho (p) 
Total difficulties score .433* (<.001)  Total difficulties score .370* (<.001) 
Subscale score   Subscale score  
Emotional problems .457* (<.001)  Emotional problems .342* (<.001) 
Conduct problems .011 (.914)  Conduct problems .132 (.183) 
Hyperactivity .184 (.064)  Hyperactivity .154 (.119) 
Peer problems .186 (.061)  Peer problems .245* (.012) 
Prosocial .118 (.239)  Prosocial -.298* (.002) 







In this clinical sample of adolescent psychiatric 
outpatients aged 12–17 years, the Swedish CSDS and 
CSDS-P showed high internal consistency, and the 
factor analyses replicated the previously shown one-
factor structure for both scales. The concurrent 
validity was weak. The factor analysis in the present 
study found one component for both scales in line 
with the English, Spanish and Swedish versions of 
the adult SDS (23, 24, 45). In this study, the ratings 
for each item and the total score of the CSDS were 
similar to the results of the validation of the adult 
SDS Swedish version performed in a young adult 
psychiatric sample (23). 
As noted, Leon et al. (25) suggested a cut-off value 
of 5 to identify cases with SDS in adults in primary 
care; Sheehan and Sheehan proposed a cut-off below 
5 as a potential remission criterion (14). In this study, 
CSDS at a cut-off 5 overlapped with more than 80% 
of the cases with at least one diagnosis. Specificity 
seemed acceptable, but due to a low number of 
patients without diagnosis, this finding is uncertain. 
We recommend the use of a cut-off for CSDS of 5 
and for CSDS-P of 17 to identify patients with low 
functioning related to a psychiatric diagnosis, 
considering  the results of previous studies 
mentioned above (14, 24), the cut-off and mean 
values previously described by Whiteside (9) for 
children with anxiety, and the results obtained for 
CSDS/CSDS-P sensitivity and specificity for at least 
one diagnosis in the present study. However, it is 
important to emphasise that some cases may have  
low levels of function without having a diagnosis (6) 
and that the rate of undiagnosed patients was very 
low due to the characteristics of the population, 
which decreases the precision of the measurements 
and hinders a generalization of applicability to other 
populations. 
There were weak general correlations between the 
CSDS/CSDS-P and the K-SADS symptom 
summation index, as well as with the SDQ. The only 
exception was the K-SADS symptom summation for 
MDD together with the SDQ adolescent total 
difficulties and emotional problems, which were low 
but still significant, as opposed to other correlations 
with SDQ, which were negligible. The correlation 
with the SDQ emotional subscale indicates increased 
adolescent awareness of depressive symptoms and is 
consistent with expectations (46). 
Interestingly, the correlation between the total 
score on the CSDS-P and that on the SDQ parent 
version was lower than that for the adolescent report, 
which might be explained by the tendency of 
adolescents to under-report depressive symptoms to 
their parents (47, 48).  
Notably, high correlations with adolescent reports 
of dysfunction in the manic episode and with 
parental reports of dysfunction in adolescents’ 
psychotic episodes were found when the correlations 
of the CSDS/CSDS-P with the K-SADS function 
summation index were separated for each diagnosis. 
This suggests the ability of the scales to identify 
differences in functioning in various disorders with 
severe symptoms despite apparent low overall 
correlations. However, one should bear in mind that 
the prevalence of mood disorders with severe 
impairment in U.S adolescents is 11.2% according to 
the epidemiological study performed by Merikangas 
et al.  (49), and that in our study only 1.8% presented 
severe mood disorders, because the most severe 
cases did not receive outpatient care and therefore 
were not included in the study. The generalization of 
these conclusions is limited by the small number of 
cases in the sample. 
Moreover, the relationship between the total score 
on the CSDS/CSDS-P and the number of diagnoses 
was weak. If one observes only the correlation 
coefficients, which are based on the notion of 
linearity, and the whole range of the compared scales, 
one might overlook that the correlation could be 
negligible at one end of the continuum and very high 
at the other end. If so, a low or mediocre correlation 





would result when the total correlations are 
compared. 
However, this phenomenon elucidates the 
problem with statistical measures that are built to 
estimate the magnitude of association compared with 
the actual agreement at a certain cut-off (such as the 
suggested score of 5)(50). 
The results highlight a number of issues. First, 
adolescent self-reports of low functioning levels were 
in line with expert raters using a standardised 
diagnostic instrument. Second, correlation tests that 
use the full range of variation, which is better suited 
for detecting covariance, might risk revealing the low 
usefulness of a scale, which should be able to detect 
disability that meets the impairment criteria for a 
psychiatric disorder when a certain cut-off has been 
reached. Therefore, we propose that the CSDS and 
CSDS-P scales could provide complementary 




The study was performed in a clinical population 
with multiple diagnoses and most of the participants 
had comorbid disorders. This limits its 
generalizability in diagnosing specific populations. 
On the other hand, our results are not limited to 
patients with a specific diagnosis (27). An additional 
limitation is the absence of a comparative community 
sample to evaluate the psychometric properties of 
the scales in different settings. Moreover, the small 
number of undiagnosed patients as well as the small 
sample size decreased the accuracy of the 
measurement of sensitivity and specificity. 
A further limitation in the design is that no other 
specific scales for measuring functioning were 
included. However, the K-SADS, a “gold standard” 
among diagnostic interviews, was used to identify 
diagnoses and to have a diagnosis imply a clinical 
level of dysfunction. Therefore, this assessment was 
considered to be a relevant reference for the CSDS.  
In addition, the interview was conducted first, and 
then the scale was completed, which may have 
influenced the performance of the scale.  
 
Strengths 
The study compares the CSDS and CSDS-P against 
the sum of symptoms and number of diagnoses 
obtained by using the “gold standard” K-SADS-PL 
interview and the SDQ, an established scale for 
measuring strengths and difficulties. The CSDS and 
CSDS-P are self-report and parent-report scales, 
respectively. They are easy to use and help to identify 
dysfunction caused by mental health problems, and 
thereby identify individuals who need subsequent 
evaluation.  
 
Clinical significance  
The results indicate that the Swedish versions of the 
CSDS and CSDS-P have similar psychometric 
properties to the Swedish, English and Spanish 
versions of the adult SDS, and the English versions 
of the CSDS and CSDS-P. Concurrent validity and 
correlations with symptoms and functional indexes 
based on the K-SADS were low, probably due to the 
impact of differences in the individuals’ functional 
levels.  
However, the symptoms of diagnoses with a severe 
impact on the function level showed higher 
correlations with the rated function in the 
CSDS/CSDS-P.  
The CSDS/CSDS-P correctly identified more than 
80% of cases with at least one diagnosis at the 
proposed cut-off value of 5 and 17, respectively. 
They could therefore be useful in adolescent mental 
health services in a Swedish population. 
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